From fooui@canepo.info  Sun Apr 10 11:28:08 2005
Return-Path: <fooui@canepo.info>
Received: from 66.136.223.122 ([218.86.43.163])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3AGRsAQ008676;
	Sun, 10 Apr 2005 11:28:00 -0500
Received: from permutation.aventuraspanama.com ([69.89.71.4])
 by longhand.1001getaways.com (Sun Java System Messaging Server 6.1 HotFix 0.06
 (built Oct 24 2004)) with ESMTP id <0IDD000LCGU1W5B8@longhand.1001getaways.com> for
 cypherpunks@al-qaeda.net (ORCPT cypherpunks@al-qaeda.net); Mon, 11 Apr 2005 15:27:24 +0400 (IST)
Received: from hibernia
 (IOTO-536-450.aventuraspanama.com [67.109.120.11] (may be forged))
	by permutation.aventuraspanama.com (MOS 3.2.4-GR)	with ESMTP id DBZ28245 (AUTH hibernia-03)
 ; Mon, 11 Apr 2005 07:27:24 -0400 (IST)
Date: Mon, 11 Apr 2005 07:19:24 -0400
From: "Selma Miner" <fooui@canepo.info>
To: <cypherpunks@al-qaeda.net>
Subject: Profit from unparalleled investment research
Sender: "Selma Miner" <fooui@canepo.info>
Message-ID: <013274335398.TYU04074@hibernia.aventuraspanama.com>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3436
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,0OO,OO0 EST
Current Price: O.O9
2OO4 Success |ead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industrial certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Inc|uded in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be||adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmasterol, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydrochlorrde, 10-Deacetyl Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OO0 with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy re|ating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of pheno|ic secondary 
metabolites of p|ants that include more than 2,O0O different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeabi|ity of the wal|s of the blood vesse|s including capil|aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 20O4-2O05 are more then  $1O0 mi||iOn USD

Further deve|opments of the transaction and the deve|opment at Huifeng 
should be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potentia| of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny St0cks are considered high|y specu|ative and may be unsuitable 
for a|l but very aggressive investors.  This Profile is not in any way 
affiliated with the featured company.  We were compensated 3OOO dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you fee| you have been
wrongfully p|aced in our membership, please go here or send a blank
e mail with No Thanks in the subject to   st0ck63 @  yahoo.com

